Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Biotech Fund Flanders

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$19M
Portfolio companies 6
Rounds per year 0.30
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 2
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Clinical Trials
  • Biopharma
  • Health Care
Summary

In 1994 was created Biotech Fund Flanders, which is appeared as VC. The fund was located in Europe if to be more exact in Belgium. The leading representative office of defined VC is situated in the Antwerp.

The typical case for the fund is to invest in rounds with 7-8 participants. Despite the Biotech Fund Flanders, startups are often financed by Gimv, Sofinnova Partners, Life Sciences Partners. The meaningful sponsors for the fund in investment in the same round are Gimv, Life Sciences Partners, Sofinnova Partners. In the next rounds fund is usually obtained by Gimv, MP Healthcare Venture Management, Kempen & Co.

We can highlight the next thriving fund investment areas, such as Biopharma, E-Commerce. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Diatos, Pronota, Devgen. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium.

This Biotech Fund Flanders works on 14 percentage points more the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2015. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2007.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Biotech Fund Flanders:
Typical Co-investors
Biotech Fund Flanders is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Biotech Fund Flanders:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Belgium
Funds with similar focus located in Belgium:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aquarius Equity Partners England, Manchester, United Kingdom
Chang Development Beijing, Changping, China
Crypto Dorm Fund -
INCA VENTURES -
Long Ridge Equity Partners New York, New York, United States
Milkbox Partners New York, New York, United States
PJC Boston, Massachusetts, United States
Qinxing Technology China, Guangdong Province, Huizhou
Rongsheng Chuangfu Beijing, Beijing, China
Sanquin Blood Supply Foundation -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Virovet

Biotechnology
Pharmaceutical
Veterinary
$7M28 May 2020 Leuven, Flemish Brabant, Belgium

Pronota

Biotechnology
Health Care
Health Diagnostics
$4M20 Jan 2012 Ghent, East Flanders, Belgium

Pronota

Biotechnology
Health Care
Health Diagnostics
$7M29 Jun 2009 Ghent, East Flanders, Belgium

Ablynx

$50M23 Aug 2006 -

Ablynx

$30M06 Apr 2004 -

Devgen

Mobile Apps
$27M01 Oct 1999 Lomé, Maritime Region, Togo

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Biotech Fund Flanders?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 9
Average round size 19M
Rounds per year 0.30
Peak activity year 2006
Lead investments 0
Follow on index 0.33
Exits 2
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Virovet

Biotechnology
Pharmaceutical
Veterinary
$7M28 May 2020 Leuven, Flemish Brabant, Belgium

Pronota

Biotechnology
Health Care
Health Diagnostics
$4M20 Jan 2012 Ghent, East Flanders, Belgium

Pronota

Biotechnology
Health Care
Health Diagnostics
$7M29 Jun 2009 Ghent, East Flanders, Belgium

Ablynx

$50M23 Aug 2006 -

Ablynx

$30M06 Apr 2004 -

Devgen

Mobile Apps
$27M01 Oct 1999 Lomé, Maritime Region, Togo
Crunchbase icon

Content report

The following text will be sent to our editors: